T1	CHEM 61 73	vortioxetina
#1	AnnotatorNotes T1	C3661282; vortioxetine; Organic Chemical · Pharmacologic Substance
T2	CHEM 76 90	desvenlafaxina
#2	AnnotatorNotes T2	C1880288; desvenlafaxine; Organic Chemical · Pharmacologic Substance
T3	DISO 116 125	depresión
#3	AnnotatorNotes T3	C0011570; Mental Depression; Mental or Behavioral Dysfunction | C0011581; Depressive disorder; Mental or Behavioral Dysfunction
T4	PROC 156 251	Estudio aleatorizado, con doble enmascaramiento y grupos paralelos, comparativo con tratamiento
T5	PROC 273 292	evalúan la eficacia
T6	CHEM 299 311	vortioxetina
#4	AnnotatorNotes T6	C3661282; vortioxetine; Organic Chemical · Pharmacologic Substance
T7	CHEM 323 337	desvenlafaxina
#5	AnnotatorNotes T7	C1880288; desvenlafaxine; Organic Chemical · Pharmacologic Substance
T8	DISO 370 395	trastorno depresivo mayor
#6	AnnotatorNotes T8	C1269683; Major Depressive Disorder; Mental or Behavioral Dysfunction
T9	DISO 726 729	MDE
#7	AnnotatorNotes T9	C0024517; major depressive episode; Mental or Behavioral Dysfunction
T10	DISO 970 973	MDE
#8	AnnotatorNotes T10	C0024517; major depressive episode; Mental or Behavioral Dysfunction
T11	CHEM 449 453	ISRS
#9	AnnotatorNotes T11	C0360105; Selective Serotonin Reuptake Inhibitors; Pharmacologic Substance
T12	DISO 477 486	Depresión
#10	AnnotatorNotes T12	C0011570; Mental Depression; Mental or Behavioral Dysfunction | C0011581; Depressive disorder; Mental or Behavioral Dysfunction
T13	DISO 513 538	Trastorno depresivo mayor
#11	AnnotatorNotes T13	C1269683; Major Depressive Disorder; Mental or Behavioral Dysfunction
T14	PROC 588 599	diagnóstico
#12	AnnotatorNotes T14	C0011900; Diagnosis; Diagnostic Procedure
T15	DISO 613 638	trastorno depresivo mayor
#13	AnnotatorNotes T15	C1269683; Major Depressive Disorder; Mental or Behavioral Dysfunction
T16	DISO 699 724	trastorno depresivo mayor
#14	AnnotatorNotes T16	C1269683; Major Depressive Disorder; Mental or Behavioral Dysfunction
T17	PROC 867 927	Escala de clasificación de la depresión de Montgomery-Åsberg
#15	AnnotatorNotes T17	C4545796; Assessment using MADRS (Montgomery-Åsberg Depression Rating Scale); Diagnostic Procedure
T18	DISO 897 906	depresión
#16	AnnotatorNotes T18	C0011570; Mental Depression; Mental or Behavioral Dysfunction | C0011581; Depressive disorder; Mental or Behavioral Dysfunction
T19	PROC 1061 1072	tratamiento
#17	AnnotatorNotes T19	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T20	PROC 1090 1101	monoterapia
#18	AnnotatorNotes T20	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T21	CHEM 1103 1113	citalopram
#19	AnnotatorNotes T21	C0008845; citalopram; Organic Chemical · Pharmacologic Substance
T22	CHEM 1115 1127	escitalopram
#20	AnnotatorNotes T22	C1099456; escitalopram; Organic Chemical · Pharmacologic Substance
T23	CHEM 1129 1139	paroxetina
#21	AnnotatorNotes T23	C0070122; paroxetine; Organic Chemical · Pharmacologic Substance
T24	CHEM 1142 1152	sertralina
#22	AnnotatorNotes T24	C0074393; sertraline; Organic Chemical · Pharmacologic Substance
T25	PROC 929 934	MADRS
#23	AnnotatorNotes T25	C4545796; Assessment using MADRS (Montgomery-Åsberg Depression Rating Scale); Diagnostic Procedure
T26	PROC 1300 1321	cambio de tratamiento
#24	AnnotatorNotes T26	C5392248; Treatment Switching; Health Care Activity
T27	PROC 1344 1380	cambiar de tratamiento antidepresivo
T28	DISO 1482 1491	trastorno
#25	AnnotatorNotes T28	C0012634; Disease; Disease or Syndrome
T29	PROC 1497 1508	tratamiento
#26	AnnotatorNotes T29	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T30	PROC 1534 1545	tratamiento
#27	AnnotatorNotes T30	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T31	PROC 1588 1599	tratamiento
#28	AnnotatorNotes T31	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T32	DISO 1554 1557	MDE
#29	AnnotatorNotes T32	C0024517; major depressive episode; Mental or Behavioral Dysfunction
T33	PROC 433 444	tratamiento
#30	AnnotatorNotes T33	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T34	CHEM 1080 1084	ISRS
#31	AnnotatorNotes T34	C0360105; Selective Serotonin Reuptake Inhibitors; Pharmacologic Substance
T35	CHEM 1367 1380	antidepresivo
#32	AnnotatorNotes T35	C0003289; Antidepressive Agents; Pharmacologic Substance
T36	DISO 1212 1215	MDE
#33	AnnotatorNotes T36	C0024517; major depressive episode; Mental or Behavioral Dysfunction
T37	Date 13 17	2019
T39	LIVB 94 111	pacientes adultos
#34	AnnotatorNotes T39	C0030705; Patients; Patient or Disabled Group + C0001675; Adult; Age Group
T41	LIVB 341 358	pacientes adultos
#35	AnnotatorNotes T41	C0030705; Patients; Patient or Disabled Group + C0001675; Adult; Age Group
T42	LIVB 570 578	paciente
#36	AnnotatorNotes T42	C0030705; Patients; Patient or Disabled Group
T43	Date 689 695	actual
T44	LIVB 821 829	paciente
#37	AnnotatorNotes T44	C0030705; Patients; Patient or Disabled Group
T45	Date 974 980	actual
T46	LIVB 985 993	paciente
#38	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group
T47	Duration 1013 1033	≥3 meses y <12 meses
T49	LIVB 1040 1048	paciente
#39	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	Duration 1162 1180	al menos 6 semanas
T52	Date 1216 1222	actual
T53	LIVB 1269 1281	investigador
#40	AnnotatorNotes T53	C0035173; Research Personnel; Professional or Occupational Group
T55	LIVB 1328 1336	paciente
#41	AnnotatorNotes T55	C0030705; Patients; Patient or Disabled Group
T56	LIVB 1461 1469	paciente
#42	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T38	PROC 760 807	Mini Entrevista Neuropsiquiátrica Internacional
#43	AnnotatorNotes T38	C5396266; Assessment using the Mini International Neuropsychiatric Interview; Health Care Activity
T40	PROC 809 813	MINI
A1	Population_data T39 Age
A2	Population_data T41 Age
#44	AnnotatorNotes T4	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure + C0013072; Double-Blind Method; Research Activity + C0034656; Randomization; Research Activity + C2826345; Parallel Study; Research Activity  + C1579762; comparative study research; Research Activity
#45	AnnotatorNotes T5	C1707887; Efficacy Study; Research Activity
#46	AnnotatorNotes T40	C5396266; Assessment using the Mini International Neuropsychiatric Interview; Health Care Activity
#47	AnnotatorNotes T45	C0521116; Current (present time); Temporal Concept 
#48	AnnotatorNotes T43	C0521116; Current (present time); Temporal Concept 
#49	AnnotatorNotes T52	C0521116; Current (present time); Temporal Concept 
T48	CONC 1570 1580	interferir
A3	Assertion T48 Speculated
#50	AnnotatorNotes T48	C0521102; Interferes with; Functional Concept
T51	Spec_cue 1564 1569	puede
T54	Neg_cue 1614 1621	impedir
T57	Observation 1625 1649	cumplimiento terapéutico
A4	Assertion T57 Negated
#51	AnnotatorNotes T57	C2364172; Adherence To Medication Regime; Finding
R1	Negation Arg1:T54 Arg2:T57	
R2	Speculation Arg1:T51 Arg2:T48	
T58	Spec_cue 1385 1391	podrán
T59	CONC 1406 1428	criterios de inclusión
A5	Assertion T59 Speculated
#52	AnnotatorNotes T59	C1512693; Inclusion Criteria; Qualitative Concept
T60	Quantifier_or_Qualifier 1400 1405	otros
A6	Assertion T60 Speculated
R3	Has_Quantifier_or_Qualifier Arg1:T59 Arg2:T60	
R4	Speculation Arg1:T58 Arg2:T60	
R5	Speculation Arg1:T58 Arg2:T59	
T61	Spec_cue 1651 1660	Se podrán
T62	Quantifier_or_Qualifier 1669 1674	otros
A7	Assertion T62 Speculated
T63	CONC 1675 1697	criterios de exclusión
A8	Assertion T63 Speculated
#53	AnnotatorNotes T63	C0680251; Exclusion Criteria; Functional Concept
R6	Has_Quantifier_or_Qualifier Arg1:T63 Arg2:T62	
R7	Speculation Arg1:T61 Arg2:T62	
R8	Speculation Arg1:T61 Arg2:T63	
T64	Observation 412 429	respuesta parcial
#54	AnnotatorNotes T64	C1521726; partial response; Finding
R9	Overlap Arg1:T64 Arg2:T33	
R10	Used_for Arg1:T11 Arg2:T33	
T65	Observation 1233 1250	respuesta parcial
#55	AnnotatorNotes T65	C1521726; partial response; Finding
R11	Experiences Arg1:T39 Arg2:T1	
R12	Experiences Arg1:T39 Arg2:T2	
R13	Experiences Arg1:T39 Arg2:T3	
R14	Experiences Arg1:T41 Arg2:T6	
R15	Experiences Arg1:T41 Arg2:T7	
R16	Experiences Arg1:T41 Arg2:T8	
R17	Overlap Arg1:T8 Arg2:T64	
R18	Experiences Arg1:T41 Arg2:T64	
R19	Experiences Arg1:T41 Arg2:T33	
R20	Experiences Arg1:T42 Arg2:T15	
T66	CONC 669 674	DSM-5
#56	AnnotatorNotes T66	C4236906; Diagnostic and Statistical Manual of Mental Disorders, Fift Edition (DSM-5); Intellectual Product4
R21	Used_for Arg1:T66 Arg2:T14	
T67	Observation 649 659	recurrente
#57	AnnotatorNotes T67	C0679254; Disease recurrence; Finding
R22	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T67	
R23	Experiences Arg1:T42 Arg2:T67	
R24	Overlap Arg1:T16 Arg2:T43	
R25	Overlap Arg1:T9 Arg2:T43	
T68	Result_or_Value 857 860	≥24
R30	Has_Result_or_Value Arg1:T17 Arg2:T68	
R31	Has_Result_or_Value Arg1:T25 Arg2:T68	
R32	Experiences Arg1:T44 Arg2:T17	
R33	Experiences Arg1:T44 Arg2:T25	
R34	Experiences Arg1:T44 Arg2:T18	
T69	PROC 942 951	selección
#58	AnnotatorNotes T69	C0242802; Patient Selection; Research Activity
R35	Overlap Arg1:T17 Arg2:T69	
R36	Overlap Arg1:T25 Arg2:T69	
T70	CONC 957 963	inicio
#59	AnnotatorNotes T70	C4684789; Study Start; Temporal Concept | C2349982; Study start time; Temporal Concept 
R37	Overlap Arg1:T25 Arg2:T70	
R38	Overlap Arg1:T17 Arg2:T70	
R39	Overlap Arg1:T10 Arg2:T45	
R40	Experiences Arg1:T46 Arg2:T10	
R41	Has_Duration_or_Interval Arg1:T10 Arg2:T47	
T71	Quantifier_or_Qualifier 639 646	puntual
R42	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T71	
R43	Experiences Arg1:T49 Arg2:T19	
R44	Used_for Arg1:T34 Arg2:T19	
R45	Experiences Arg1:T49 Arg2:T20	
R46	Used_for Arg1:T21 Arg2:T20	
R47	Used_for Arg1:T22 Arg2:T20	
R48	Used_for Arg1:T23 Arg2:T20	
R49	Used_for Arg1:T24 Arg2:T20	
R50	Has_Duration_or_Interval Arg1:T34 Arg2:T50	
R51	Has_Duration_or_Interval Arg1:T21 Arg2:T50	
R52	Has_Duration_or_Interval Arg1:T22 Arg2:T50	
R53	Has_Duration_or_Interval Arg1:T23 Arg2:T50	
R54	Has_Duration_or_Interval Arg1:T24 Arg2:T50	
R55	Experiences Arg1:T49 Arg2:T36	
R56	Overlap Arg1:T36 Arg2:T52	
R57	Overlap Arg1:T19 Arg2:T65	
R58	Overlap Arg1:T20 Arg2:T65	
R59	Overlap Arg1:T36 Arg2:T65	
R60	Experiences Arg1:T49 Arg2:T65	
R61	Experiences Arg1:T49 Arg2:T26	
R62	Before Arg1:T19 Arg2:T26	
R63	Before Arg1:T20 Arg2:T26	
R64	Before Arg1:T65 Arg2:T26	
R65	Experiences Arg1:T55 Arg2:T27	
T72	Observation 1337 1343	quiere
#60	AnnotatorNotes T72	C0600109; Willing; Finding
R66	Overlap Arg1:T72 Arg2:T27	
R68	Used_for Arg1:T35 Arg2:T27	
R69	Experiences Arg1:T56 Arg2:T28	
T73	Quantifier_or_Qualifier 1477 1481	otro
#61	AnnotatorNotes T73	C0205394; Other; Qualitative Concept
R70	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T73	
R71	Experiences Arg1:T56 Arg2:T29	
R72	Experiences Arg1:T56 Arg2:T30	
R73	Experiences Arg1:T56 Arg2:T32	
R75	Experiences Arg1:T56 Arg2:T31	
R76	Before Arg1:T28 Arg2:T57	
R78	Before Arg1:T29 Arg2:T57	
R80	Overlap Arg1:T30 Arg2:T57	
#62	AnnotatorNotes T71	C0205171; Singular; Quantitative Concept
R26	Experiences Arg1:T44 Arg2:T69	
#63	AnnotatorNotes T60	C0205394; Other; Qualitative Concept
#64	AnnotatorNotes T62	C0205394; Other; Qualitative Concept
A9	Experiencer T39 Patient
A10	Experiencer T41 Patient
A11	Experiencer T42 Patient
A12	Experiencer T44 Patient
A13	Experiencer T46 Patient
A14	Experiencer T49 Patient
A15	Experiencer T53 Other
A16	Experiencer T55 Patient
A17	Experiencer T56 Patient
